中华消化杂志
中華消化雜誌
중화소화잡지
Chinese Journal of Digestion
2011年
12期
812-816
,共5页
蒋益%裴继华%林李淼%徐昌隆%王建嶂%申苏建%薛战雄
蔣益%裴繼華%林李淼%徐昌隆%王建嶂%申囌建%薛戰雄
장익%배계화%림리묘%서창륭%왕건장%신소건%설전웅
结肠炎,溃疡性%细胞凋亡%肿瘤坏死因子%配体%多态现象,遗传%单倍性
結腸炎,潰瘍性%細胞凋亡%腫瘤壞死因子%配體%多態現象,遺傳%單倍性
결장염,궤양성%세포조망%종류배사인자%배체%다태현상,유전%단배성
Colitis,ulcerative%Apoptosis%Tumor necrosis factor%Ligands%Polymorphism,genetic%Haploidy
目的 探讨肿瘤坏死因子相关凋亡诱导配体(Trail)基因多态性及单倍型与溃疡性结肠炎(UC)的关系.方法 收集UC患者331例,健康对照者832名,PCR扩增Trail目的基因后,直接测序检测Trail基因3非编码区(G1525A/G1588A/C1595T)三种单核苷酸多态性,并分析Trail单倍型与UC的关系.结果 与对照组相比较,Trail G1525A突变等位基因A和基因型GA+ AA的频率在UC组中明显降低(P值均<0.01);UC组Trail G1588A和C1595T两位点突变等位基因A和T的频率明显低于对照组,且差异有统计学意义(P值均<0.01).轻和中度UC患者Trail C1595T突变等位基因T和CT+ TT基因型频率为49.15%和64.51%,重度UC患者分别为72.37%和84.21%,两组比较差异均有统计学意义(OR值分别=2.710和2.935,95%CI:1.598~4.596和1.188~7.249,P值均<0.05).重度UC患者Trail G1525A突变等位基因A的频率为48.69%,较轻和中度UC患者(35.16%)增加(OR=1.750,95%CI:1.082~2.830,P=0.021).UC组中AAT单倍型频率显著低于对照组(43.09%比58.41%,95%CI:1.549~2.229,P<0.01);GAT单倍型频率在UC组中明显增高(10.15%比0.18%,95%CI:0.005~0.051,P<0.01).结论 Trail基因多态性及单倍型与UC易感性密切相关.
目的 探討腫瘤壞死因子相關凋亡誘導配體(Trail)基因多態性及單倍型與潰瘍性結腸炎(UC)的關繫.方法 收集UC患者331例,健康對照者832名,PCR擴增Trail目的基因後,直接測序檢測Trail基因3非編碼區(G1525A/G1588A/C1595T)三種單覈苷痠多態性,併分析Trail單倍型與UC的關繫.結果 與對照組相比較,Trail G1525A突變等位基因A和基因型GA+ AA的頻率在UC組中明顯降低(P值均<0.01);UC組Trail G1588A和C1595T兩位點突變等位基因A和T的頻率明顯低于對照組,且差異有統計學意義(P值均<0.01).輕和中度UC患者Trail C1595T突變等位基因T和CT+ TT基因型頻率為49.15%和64.51%,重度UC患者分彆為72.37%和84.21%,兩組比較差異均有統計學意義(OR值分彆=2.710和2.935,95%CI:1.598~4.596和1.188~7.249,P值均<0.05).重度UC患者Trail G1525A突變等位基因A的頻率為48.69%,較輕和中度UC患者(35.16%)增加(OR=1.750,95%CI:1.082~2.830,P=0.021).UC組中AAT單倍型頻率顯著低于對照組(43.09%比58.41%,95%CI:1.549~2.229,P<0.01);GAT單倍型頻率在UC組中明顯增高(10.15%比0.18%,95%CI:0.005~0.051,P<0.01).結論 Trail基因多態性及單倍型與UC易感性密切相關.
목적 탐토종류배사인자상관조망유도배체(Trail)기인다태성급단배형여궤양성결장염(UC)적관계.방법 수집UC환자331례,건강대조자832명,PCR확증Trail목적기인후,직접측서검측Trail기인3비편마구(G1525A/G1588A/C1595T)삼충단핵감산다태성,병분석Trail단배형여UC적관계.결과 여대조조상비교,Trail G1525A돌변등위기인A화기인형GA+ AA적빈솔재UC조중명현강저(P치균<0.01);UC조Trail G1588A화C1595T량위점돌변등위기인A화T적빈솔명현저우대조조,차차이유통계학의의(P치균<0.01).경화중도UC환자Trail C1595T돌변등위기인T화CT+ TT기인형빈솔위49.15%화64.51%,중도UC환자분별위72.37%화84.21%,량조비교차이균유통계학의의(OR치분별=2.710화2.935,95%CI:1.598~4.596화1.188~7.249,P치균<0.05).중도UC환자Trail G1525A돌변등위기인A적빈솔위48.69%,교경화중도UC환자(35.16%)증가(OR=1.750,95%CI:1.082~2.830,P=0.021).UC조중AAT단배형빈솔현저저우대조조(43.09%비58.41%,95%CI:1.549~2.229,P<0.01);GAT단배형빈솔재UC조중명현증고(10.15%비0.18%,95%CI:0.005~0.051,P<0.01).결론 Trail기인다태성급단배형여UC역감성밀절상관.
Objective To explore the association between genetic polymorphisms and haplotypes of tumor necrosis factor-related apoptosis inducing ligand (Trail) and ulcerative colitis (UC).Methods A total of 331 patients with UC and 832 age and sex-matched healthy controls were collected.After Trail gene was amplified by PCR,the genetic polymorphisms of three single nucleotides (G1525A/G1588A/C1595T) in 3' non coding regions of Trail gene were examined by direct sequencing.The relation between Trail haplotype and UC was analyzed.Results Compared with control group,the frequencies of variant allele A and genotype GA+ AA in Trail G1525A were significantly lower in UC group (both P<0.01).The frequencies of variant allele A and T in Trail G1588A and C1595T were also significantly lower in UC group than that of control group,and the difference was statistically significant (both P < 0.01 ).In mild and moderate UC patients,the frequencies of variant allele T and CT+TT in Trail C1595T were 49.15% and 64.51%,in severe UC patients were 72.37% and 84.21%,and the differences were significant between the two groups (OR=2.710 and 2.935,95%CI:1.598~4.596 and 1.188~7.249,all P <0.05).In severe UC patients,the frequency of variant allele A in Trail G1525A was 48.69%,which was higher than that of mild and moderate patients (35.16%,OR=1.750,95%CI:1.082~2.830,P=0.021).In UC group,the frequency of AAT haplotype was significantly lower than that of controls (43.09% vs 58.41%,P<0.01).The frequency of GAT haplotype was significantly higher in UC group (10.15%vs 0.18%,95% CI:0.005 ~ 0.051,P< 0.01).Conclusion The genetic polymorphisms and haplotypes of Trail (G1525A/G1588A/C1595T) gene may be closely correlated with the susceptibility to UC.